IP Library Granted Patent US 11,554,117
Granted Patent B2
US 11,554,117 · App. 16/031,250 · Granted Jan 17, 2023

Glutamate agents in the treatment of mental disorders

Inventors: Vladimir Coric (Madison, CT); John H. Krystal (Woodbridge, CT); Gerard Sanacora (Guilford, CT)
Assignee: YALE UNIVERSITY
A61K31/485A61K31/13A61K31/198A61K31/425A61K31/428A61K31/43A61K31/545A61K45/06G02B1/10G02B5/281G02B5/283G02B5/285H01L27/14621H01L27/14685
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,554,117
App. No.
16/031,250
Granted
Jan 17, 2023
Kind
B2
Abstract

Methods of treating mental disorders, including anxiety disorders such as obsessive-compulsive disorder, are provided. The methods comprise administering an effective amount of a glutamate modulator to an individual in need thereof. Also provided are methods of enhancing the activity of a serotonin reuptake inhibitor (SRI) comprising co-administering a glutamate modulator and a serotonin reuptake inhibitor. Pharmaceutical composition comprising a serotonin reuptake inhibitor and a glutamate modulator are also provided.

Claims (2)

1. A method of treating a mental disorder in an individual in need thereof comprising administering to said individual an effective amount of riluzole alone in pharmaceutical dosage form, wherein said mental disorder is post-traumatic stress disorder.

2. The method according to claim 1 wherein said riluzole is administered in oral dosage form.

Continuity (8)
Continuation 14278573 · May 15, 2014
Division 11399188 · Apr 5, 2006
Provisional Application 60668735 · Apr 5, 2005
Provisional Application 60669774 · Apr 7, 2005
Provisional Application 60690187 · Jun 13, 2005
Provisional Application 60694621 · Jun 27, 2005
Provisional Application 60756472 · Jan 4, 2006
Related Publication 20180318288A1 · Nov 8, 2018